[ { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#assertion", "@graph": [ { "@id": "https://uts.nlm.nih.gov/uts/umls/concept/C0429964", "http://wordnet-rdf.princeton.edu/lemma/integrate": [ { "@id": "https://uts.nlm.nih.gov/uts/umls/concept/C0871261" } ] } ] }, { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#Head", "@graph": [ { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#pubInfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#pubInfo", "@graph": [ { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#assertion", "http://www.w3.org/ns/prov#wasDerivedFrom": [ { "@id": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470835/" } ] }, { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "fD84sNq4rYPTIVNg5h6cGTBARa/R2skt4+cogYPzGaREay9z6ainfEg4vmlESrAa5dbj830u100Z8REh3ZMse1Bc1fpKR64vVOnfYfFJxLpNixkXq+CSBRgS/MVojNlXxItAUVN50tf/PEp8Cbq0R10723eG1xqR2VyM9U4NKnk=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts" } ] }, { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2021-12-16T19:30:56.445400", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-8954-0470" } ] } ] }, { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#provenance", "@graph": [ { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#assertion", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2021-12-16T19:30:56.445400", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasGeneratedBy": [ { "@value": "S&T TWOC project version 2" } ] }, { "@id": "http://purl.org/np/RAynkM4bkiWYSWI3VuGTZuXuqjFDJeUJLBrSSfdMKz-ts#version", "http://www.w3.org/ns/prov#value": [ { "@value": "2", "@type": "http://www.w3.org/2001/XMLSchema#integer" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "into the final PK / PD model, \", where dexamethasone ( DEX ) exerted dexamethasone ( DEX ) s antitumor efficacy by inhibiting the proliferation of tumor cells\", enhanced dexamethasone ( DEX ) responses by decreasing the sensitivity parameter EC(50 )" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "191", "@type": "http://www.w3.org/2001/XMLSchema#integer" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "integrated" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "[154]" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "134", "@type": "http://www.w3.org/2001/XMLSchema#integer" } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID", "http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:wdxnfuun&rows=50": [ { "@value": "wdxnfuun" } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#SENTENCE", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "The PK model of dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) as well as that of dexamethasone (DEX) with a time-dependent clearance were integrated into the final PK/PD model both using Hill’s function, where dexamethasone (DEX) exerted dexamethasone (DEX)'s antitumor efficacy by inhibiting the proliferation of tumor cells, and dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) enhanced dexamethasone (DEX) responses by decreasing the sensitivity parameter EC(50)." } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID", "http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:wdxnfuun-TRIPLE-ABSTRACT-10": [ { "@value": "wdxnfuun-TRIPLE-ABSTRACT-10" } ] }, { "@id": "https://uts.nlm.nih.gov/uts/umls/concept/C0429964", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "dependent" } ] }, { "@id": "https://uts.nlm.nih.gov/uts/umls/concept/C0871261", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "responses" } ] } ] } ]